Public filings / BEAM on Yahoo Finance (opens in a new tab)
BEAM: insider buying, 13F holders, analyst moves
Beam Therapeutics Inc - US
A summary of public filings about Beam Therapeutics Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold BEAM
Combined reported value $412.2M.
Holders among our 100 managers: 2 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Farallon Capital | $351.3M | 2.06% | Added |
| Deep Track Capital | $34.3M | 0.51% | Added |
| RTW Investments | $19.6M | 0.17% | Unchanged |
| Duquesne Family Office | $5.3M | 0.12% | New |
| Tudor Investment | $1.7M | 0.01% | Added |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.